1 Market Overview
1.1 Everolimus Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Everolimus Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5mg
1.2.3 5mg
1.2.4 7mg
1.2.5 10mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Everolimus Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Everolimus Market Size & Forecast
1.4.1 Global Everolimus Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Everolimus Sales in Volume (2017-2028)
1.4.3 Global Everolimus Price (2017-2028)
1.5 Global Everolimus Production Capacity Analysis
1.5.1 Global Everolimus Total Production Capacity (2017-2028)
1.5.2 Global Everolimus Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Everolimus Market Drivers
1.6.2 Everolimus Market Restraints
1.6.3 Everolimus Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Everolimus Product and Services
2.1.4 Novartis Everolimus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Everolimus Breakdown Data by Manufacturer
3.1 Global Everolimus Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Everolimus Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Everolimus
3.4 Market Concentration Rate
3.4.1 Top 3 Everolimus Manufacturer Market Share in 2021
3.4.2 Top 6 Everolimus Manufacturer Market Share in 2021
3.5 Global Everolimus Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Everolimus Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Everolimus Market Size by Region
4.1.1 Global Everolimus Sales in Volume by Region (2017-2028)
4.1.2 Global Everolimus Revenue by Region (2017-2028)
4.2 North America Everolimus Revenue (2017-2028)
4.3 Europe Everolimus Revenue (2017-2028)
4.4 Asia-Pacific Everolimus Revenue (2017-2028)
4.5 South America Everolimus Revenue (2017-2028)
4.6 Middle East and Africa Everolimus Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Everolimus Sales in Volume by Type (2017-2028)
5.2 Global Everolimus Revenue by Type (2017-2028)
5.3 Global Everolimus Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Everolimus Sales in Volume by Application (2017-2028)
6.2 Global Everolimus Revenue by Application (2017-2028)
6.3 Global Everolimus Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Everolimus Sales by Type (2017-2028)
7.2 North America Everolimus Sales by Application (2017-2028)
7.3 North America Everolimus Market Size by Country
7.3.1 North America Everolimus Sales in Volume by Country (2017-2028)
7.3.2 North America Everolimus Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Everolimus Sales by Type (2017-2028)
8.2 Europe Everolimus Sales by Application (2017-2028)
8.3 Europe Everolimus Market Size by Country
8.3.1 Europe Everolimus Sales in Volume by Country (2017-2028)
8.3.2 Europe Everolimus Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Everolimus Sales by Type (2017-2028)
9.2 Asia-Pacific Everolimus Sales by Application (2017-2028)
9.3 Asia-Pacific Everolimus Market Size by Region
9.3.1 Asia-Pacific Everolimus Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Everolimus Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Everolimus Sales by Type (2017-2028)
10.2 South America Everolimus Sales by Application (2017-2028)
10.3 South America Everolimus Market Size by Country
10.3.1 South America Everolimus Sales in Volume by Country (2017-2028)
10.3.2 South America Everolimus Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Everolimus Sales by Type (2017-2028)
11.2 Middle East & Africa Everolimus Sales by Application (2017-2028)
11.3 Middle East & Africa Everolimus Market Size by Country
11.3.1 Middle East & Africa Everolimus Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Everolimus Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Everolimus and Key Manufacturers
12.2 Manufacturing Costs Percentage of Everolimus
12.3 Everolimus Production Process
12.4 Everolimus Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Everolimus Typical Distributors
13.3 Everolimus Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Everolimus Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Everolimus Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Everolimus Product and Services
Table 6. Novartis Everolimus Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Everolimus Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 8. Global Everolimus Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Everolimus, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Everolimus Production Capacity by Company, (MT): 2020 VS 2021
Table 11. Head Office and Everolimus Production Site of Key Manufacturer
Table 12. Everolimus New Entrant and Capacity Expansion Plans
Table 13. Everolimus Mergers & Acquisitions in the Past Five Years
Table 14. Global Everolimus Sales by Region (2017-2022) & (MT)
Table 15. Global Everolimus Sales by Region (2023-2028) & (MT)
Table 16. Global Everolimus Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Everolimus Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Everolimus Sales by Type (2017-2022) & (MT)
Table 19. Global Everolimus Sales by Type (2023-2028) & (MT)
Table 20. Global Everolimus Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Everolimus Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Everolimus Price by Type (2017-2022) & (USD/Kg)
Table 23. Global Everolimus Price by Type (2023-2028) & (USD/Kg)
Table 24. Global Everolimus Sales by Application (2017-2022) & (MT)
Table 25. Global Everolimus Sales by Application (2023-2028) & (MT)
Table 26. Global Everolimus Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Everolimus Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Everolimus Price by Application (2017-2022) & (USD/Kg)
Table 29. Global Everolimus Price by Application (2023-2028) & (USD/Kg)
Table 30. North America Everolimus Sales by Country (2017-2022) & (MT)
Table 31. North America Everolimus Sales by Country (2023-2028) & (MT)
Table 32. North America Everolimus Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Everolimus Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Everolimus Sales by Type (2017-2022) & (MT)
Table 35. North America Everolimus Sales by Type (2023-2028) & (MT)
Table 36. North America Everolimus Sales by Application (2017-2022) & (MT)
Table 37. North America Everolimus Sales by Application (2023-2028) & (MT)
Table 38. Europe Everolimus Sales by Country (2017-2022) & (MT)
Table 39. Europe Everolimus Sales by Country (2023-2028) & (MT)
Table 40. Europe Everolimus Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Everolimus Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Everolimus Sales by Type (2017-2022) & (MT)
Table 43. Europe Everolimus Sales by Type (2023-2028) & (MT)
Table 44. Europe Everolimus Sales by Application (2017-2022) & (MT)
Table 45. Europe Everolimus Sales by Application (2023-2028) & (MT)
Table 46. Asia-Pacific Everolimus Sales by Region (2017-2022) & (MT)
Table 47. Asia-Pacific Everolimus Sales by Region (2023-2028) & (MT)
Table 48. Asia-Pacific Everolimus Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Everolimus Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Everolimus Sales by Type (2017-2022) & (MT)
Table 51. Asia-Pacific Everolimus Sales by Type (2023-2028) & (MT)
Table 52. Asia-Pacific Everolimus Sales by Application (2017-2022) & (MT)
Table 53. Asia-Pacific Everolimus Sales by Application (2023-2028) & (MT)
Table 54. South America Everolimus Sales by Country (2017-2022) & (MT)
Table 55. South America Everolimus Sales by Country (2023-2028) & (MT)
Table 56. South America Everolimus Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Everolimus Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Everolimus Sales by Type (2017-2022) & (MT)
Table 59. South America Everolimus Sales by Type (2023-2028) & (MT)
Table 60. South America Everolimus Sales by Application (2017-2022) & (MT)
Table 61. South America Everolimus Sales by Application (2023-2028) & (MT)
Table 62. Middle East & Africa Everolimus Sales by Region (2017-2022) & (MT)
Table 63. Middle East & Africa Everolimus Sales by Region (2023-2028) & (MT)
Table 64. Middle East & Africa Everolimus Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Everolimus Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Everolimus Sales by Type (2017-2022) & (MT)
Table 67. Middle East & Africa Everolimus Sales by Type (2023-2028) & (MT)
Table 68. Middle East & Africa Everolimus Sales by Application (2017-2022) & (MT)
Table 69. Middle East & Africa Everolimus Sales by Application (2023-2028) & (MT)
Table 70. Everolimus Raw Material
Table 71. Key Manufacturers of Everolimus Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Everolimus Typical Distributors
Table 75. Everolimus Typical Customers
List of Figures
Figure 1. Everolimus Picture
Figure 2. Global Everolimus Revenue Market Share by Type in 2021
Figure 3. 2.5mg
Figure 4. 5mg
Figure 5. 7mg
Figure 6. 10mg
Figure 7. Global Everolimus Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Other
Figure 11. Global Everolimus Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 12. Global Everolimus Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Everolimus Sales (2017-2028) & (MT)
Figure 14. Global Everolimus Price (2017-2028) & (USD/Kg)
Figure 15. Global Everolimus Production Capacity (2017-2028) & (MT)
Figure 16. Global Everolimus Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Everolimus Market Drivers
Figure 18. Everolimus Market Restraints
Figure 19. Everolimus Market Trends
Figure 20. Global Everolimus Sales Market Share by Manufacturer in 2021
Figure 21. Global Everolimus Revenue Market Share by Manufacturer in 2021
Figure 22. Everolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Everolimus Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Everolimus Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Everolimus Sales Market Share by Region (2017-2028)
Figure 26. Global Everolimus Revenue Market Share by Region (2017-2028)
Figure 27. North America Everolimus Revenue (2017-2028) & (USD Million)
Figure 28. Europe Everolimus Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Everolimus Revenue (2017-2028) & (USD Million)
Figure 30. South America Everolimus Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Everolimus Revenue (2017-2028) & (USD Million)
Figure 32. Global Everolimus Sales Market Share by Type (2017-2028)
Figure 33. Global Everolimus Revenue Market Share by Type (2017-2028)
Figure 34. Global Everolimus Price by Type (2017-2028) & (USD/Kg)
Figure 35. Global Everolimus Sales Market Share by Application (2017-2028)
Figure 36. Global Everolimus Revenue Market Share by Application (2017-2028)
Figure 37. Global Everolimus Price by Application (2017-2028) & (USD/Kg)
Figure 38. North America Everolimus Sales Market Share by Type (2017-2028)
Figure 39. North America Everolimus Sales Market Share by Application (2017-2028)
Figure 40. North America Everolimus Sales Market Share by Country (2017-2028)
Figure 41. North America Everolimus Revenue Market Share by Country (2017-2028)
Figure 42. United States Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Everolimus Sales Market Share by Type (2017-2028)
Figure 46. Europe Everolimus Sales Market Share by Application (2017-2028)
Figure 47. Europe Everolimus Sales Market Share by Country (2017-2028)
Figure 48. Europe Everolimus Revenue Market Share by Country (2017-2028)
Figure 49. Germany Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Everolimus Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Everolimus Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Everolimus Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Everolimus Revenue Market Share by Region (2017-2028)
Figure 58. China Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Everolimus Sales Market Share by Type (2017-2028)
Figure 65. South America Everolimus Sales Market Share by Application (2017-2028)
Figure 66. South America Everolimus Sales Market Share by Country (2017-2028)
Figure 67. South America Everolimus Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Everolimus Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Everolimus Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Everolimus Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Everolimus Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Everolimus Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Everolimus in 2021
Figure 79. Manufacturing Process Analysis of Everolimus
Figure 80. Everolimus Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

※参考情報 エベロリムスとは、主にがん治療や移植後の免疫抑制に用いられる薬剤であり、日本国内外で広く使用されています。この薬剤は、マトリックス内のサイクリン依存性キナーゼインヒビターであり、特にmTOR（mechanistic Target of Rapamycin）経路を阻害することにより、細胞の成長や増殖、代謝に影響を与えることが特徴です。エベロリムスは、特に腫瘍細胞の増殖を抑制する作用があるため、がん治療において非常に重要な役割を果たしています。また、移植においては、拒絶反応を抑える効果も期待されています。 エベロリムスの特性として、その作用機序が挙げられます。mTOR経路は、細胞の成長や増殖、エネルギー代謝、タンパク質合成に深く関与しています。このため、エベロリムスによってmTORが阻害されることで、がん細胞の増殖が抑制されたり、細胞周期が調整されたりすることが可能となります。これにより、腫瘍の成長を抑える効果が期待され、さまざまながんに対して使用されます。 エベロリムスは、主に以下の疾患に用いられます。まず、腎細胞癌や乳癌など、特定のタイプの固形腫瘍に対しては、これらのがん細胞のmTOR経路を介した増殖を阻害する効果があります。また、神経内分泌腫瘍や皮膚腫瘍、特に結節性硬化症に関連する腫瘍にも効果が報告されています。さらに、臓器移植後の免疫抑制治療においても、エベロリムスは使用され、拒絶反応を減少させるために重要な役割を果たします。これにより、移植された臓器の寿命を延ばすことが期待されます。 エベロリムスの形態としては、主に錠剤として提供されていますが、経口投与が主流であるため、患者が自宅で簡単に服用することができるという利点があります。投与量や服用方法は、患者の状態に応じて調整されることが一般的であり、副作用や合併症を考慮しながら慎重に管理されます。 エベロリムスを使用する際には、副作用にも注意が必要です。一般的な副作用としては、口内炎、皮疹、感染症のリスク増加、肝機能障害、高血糖などがあります。これらの副作用は、患者によってその発現度や重症度が異なるため、定期的なフォローアップが重要です。また、エベロリムスは他の薬剤と相互作用を示すことがあるため、併用療法を行う際には十分な注意が必要です。 関連技術としては、エベロリムスを含む分子標的療法があります。この治療法は、特定の分子や経路をターゲットとすることで、がん細胞のみを選択的に攻撃することができるため、従来の化学療法と比較して副作用が少ないという特徴があります。このようなアプローチは、がん治療における新しいパラダイムを提供しており、エベロリムスのような薬剤がその中心的な役割を果たしています。 さらに、エベロリムスは、新しいがん治療の研究や臨床試験においても注目されています。特に、個別化医療の観点から、患者の遺伝子情報に基づいて適切な治療法を選択することが重要視されています。このため、エベロリムスを含む治療が個別の患者にとって最も効果的であるかどうかを評価するための臨床試験が進められています。 エベロリムスの利用において留意すべき点の一つは、その長期使用の影響です。がん患者や移植患者において長期間使用されることが多いため、慢性的な副作用のモニタリングや、治療の効果を持続させるための戦略が求められています。今後さらなる研究が進む中で、より効果的な利用法や新たな治療法の開発が期待されます。 結論として、エベロリムスはがん治療や移植後の免疫抑制において重要な医薬品であり、その特性や用途において広い範囲の応用がなされています。今後の研究や臨床応用を通じて、エベロリムスの可能性はますます広がっていくことでしょう。患者一人ひとりの状況に合った治療法の選択が今後の医療の発展に寄与することを期待しています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer